Search

everythinglearnresearchcommunity

for

Search:↓

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

L-Selectin and adiponectin can help identify PCOS patients who respond to Metformin treatment.

Pantethine may boost the immune system's ability to fight sarcoma.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

The document describes a way to measure biotin in blood to prevent wrong test results in hormone level testing.

Insulin resistance is a complex condition that can lead to many diseases and has few treatment options.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Protein microarrays are highly sensitive tools useful for disease diagnosis and studying proteins.

Two-photon microscopy improves skin imaging but faces safety and cost challenges for clinical use.

Hair follicle stem cells may cause squamous cell carcinoma due to a metabolic shift towards glycolysis.

Ancient immune and signaling pathways still regulate blood cell development.

Melanoma cells lose their ability to form tumors when placed in a zebrafish embryo environment.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

MicroRNAs could help assess and manage multiple chronic diseases.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

TNF-alpha inhibitors can cause various immune-related skin issues.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Controlling immune responses with biomaterials can reduce scarring and improve skin regeneration.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

Cats can have hypersomatotropism without diabetes, suggesting current diagnosis methods may miss cases.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Immunological treatment improved both neuropathy and alopecia.